Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance. Issue 2 (April 2022)
- Record Type:
- Journal Article
- Title:
- Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance. Issue 2 (April 2022)
- Main Title:
- Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
- Authors:
- Zaratin, Paola
Banwell, Brenda
Coetzee, Timothy
Comi, Giancarlo
Feinstein, Anthony
Hyde, Robert
Salvetti, Marco
Smith, Kathryn - Abstract:
- Background: The COVID-19 pandemic has reinforced the importance of research for the health of our society and highlighted the need for stakeholders of the health research and care continuum to form a collaborative and interdependent ecosystem. Objective: With the world still reeling from waves of the COVID-19 pandemic and adapting to the vaccine rollout at widely different rates, the International Progressive MS Alliance (hereafter Alliance) organized a meeting (April 2021) to consider how the Covid-19 pandemic impacts the health and well-being of people with progressive Multiple Sclerosis (MS). Methods: We invited the Alliance stakeholders and experts to present what they have learned about SARS-CoV-2 infection and progressive MS and to define future scientific priorities. Results: The meeting highlighted three priorities for additional focus: (1) the impact of Disease Modifying Therapies (DMTs) on the risk of COVID-19 and on the efficacy of COVID-19 vaccines in people with progressive MS; (2) the long-term impact of COVID-19 and COVID-19 vaccines on the biology of progressive MS; and (3) the impact on well-being of people with progressive MS. Conclusion: This paper's calls to action could represent a path toward a shared research agenda. Multi-stakeholder and long-term investigations will be required to drive and evolve such an agenda.
- Is Part Of:
- Multiple sclerosis journal, experimental, translational and clinical. Volume 8:Issue 2(2022)
- Journal:
- Multiple sclerosis journal, experimental, translational and clinical
- Issue:
- Volume 8:Issue 2(2022)
- Issue Display:
- Volume 8, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 8
- Issue:
- 2
- Issue Sort Value:
- 2022-0008-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-04
- Subjects:
- Multiple sclerosis -- progression -- COVID-19 pandemic -- multi-stakeholder agendas
Multiple sclerosis -- Periodicals
616.834 - Journal URLs:
- https://journals.sagepub.com/home/mso ↗
http://www.uk.sagepub.com/home.nav ↗
http://mso.sagepub.com/ ↗ - DOI:
- 10.1177/20552173221099181 ↗
- Languages:
- English
- ISSNs:
- 2055-2173
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21465.xml